EHRA Premium Access

Heparin and low-molecular-weight heparin switch associated with an increase in bleeding complications in patients on apixaban undergoing catheter ablation: The AMPER ABLATION study

Presentation

About the speaker

Professor Jacques Mansourati

University Hospital of Brest, Brest (France)
1 presentation
0 follower

61 more presentations in this session

Mapping persistent atrial fibrillation with a high-density grid-style catheter: procedural characteristics and ablation lesion distribution

Speaker: Professor P. Sommer (Bad Oeynhausen, DE)

Thumbnail

Distribution of reablated antral segments after initial pulmonary vein isolation with use of ablation index.

Speaker: Associate Professor K. Neven (Essen, DE)

Thumbnail

One-year clinical outcome after pulmonary vein isolation with use of ablation index in patients with persistent atrial fibrillation.

Speaker: Professor N. Reinsch (Essen, DE)

Thumbnail

Safety and feasibility of a minimally fluoroscopic approach during pulmonary vein isolation for atrial fibrillation.

Speaker: Professor N. Reinsch (Essen, DE)

Thumbnail

Safety and feasibility of pulmonary vein isolation for atrial fibrillation in morbidly obese patients with a body mass index of more than 40 kg/m2.

Speaker: Professor N. Reinsch (Essen, DE)

Thumbnail

Access the full session

Poster session 2 - Atrial Fibrillation - Treatment

Speakers: Professor J. Mansourati, Professor P. Sommer, Associate Professor K. Neven, Professor N. Reinsch, Professor N. Reinsch...
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk